Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 361021 - 361040 out of 498494 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Qatar | (L01FG01) bevacizumab | Avastin 400mg/16ml Vial | 16ml Vial,Concentrate for Solution for Infusion Vials, 16ml Vial | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | F.HoffmannLaRocheLtd. |
| Qatar | (L01FG02) ramucirumab | Cyramza 100mg/10ml Solution for I.V. Infusion | 1 Vial,Solution for I.V. Infusion Carton box containing 1 Type-I glass vial (of 10ml) with a chlorobutyl-rubber stopper and a two piece flip-top aluminum seal with a folded leaflet, 1 Vial | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | Elililly&Company |
| Qatar | (L01FG02) ramucirumab | Cyramza 500mg/50ml Solution for I.V. Infusion | 1 Vial,Solution for I.V. Infusion Carton box containing 1 Type-I glass vial (of 50ml) with a chlorobutyl-rubber stopper and a two piece flip-top aluminum seal with a folded leaflet, 1 Vial | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms | Elililly&Company |
| Qatar | (L01FX04) ipilimumab | Yervoy 50mg/10ml | 1 Vial,Solution for IV Injection Carton box containing one 10-cc Type I flint glass vial sealed with a 20mm gray butyle D777-1 reformulated B2-40/ flurotec coated serum stopper & an aluminium flip-off seal in addition to a folded pack insert., 1 Vial | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | Bristol-MyersSquibb |
| Qatar | (L01FX07) blinatumomab | Blincyto | 1 vial,Lyophilized powder in a single-use vial for reconstitution 1 single-use vial+ 1 IV solution stabilizer single-use vial, 1 vial | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenInc. |
| Qatar | (L01FX12) tafasitamab | Minjuvi 200mg Powder for Concentrate for Solution for Infusion | 1s,Powder for Concentrate for Solution for Infusion Vial, 1s | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | IncyteBiosciencesInternationalSàrl |
| Qatar | (L01FX14) polatuzumab vedotin | Polivy 30mg Powder for Concentrate for Solution for Infusion | 1s,Powder for Concentrate for Solution for Infusion Vial, 1s | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | F.HoffmannLaRocheLtd. |
| Qatar | (L01FX18) amivantamab | Rybrevant 350mg (50mg/ml) | 1s (of 7ml),Concentrate for solution for infusion Vial, 1s (of 7ml) | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | JanssenCilagInternationalN.V. |
| Qatar | (L01FX24) teclistamab | Tecvayli 10mg/ml Solution for S.C. Injection | 1s (of 3ml),Solution for S.C. Injection Vial, 1s (of 3ml) | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | JanssenCilagInternationalN.V. |
| Qatar | (L01FX24) teclistamab | Tecvayli 153mg/1.7ml Solution for S.C. Injection | 1s (of 1.7ml),Solution for S.C. Injection Vial, 1s (of 1.7ml) | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | JanssenCilagInternationalN.V. |
| Qatar | (L01FX25) mosunetuzumab | Lunsumio 1mg/1ml Concentrate for Solution for Infusion | 1’s,Concentrate for Solution for Infusion Vial, 1’s | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | F.HoffmannLaRocheLtd., |
| Qatar | (L01FX25) mosunetuzumab | Lunsumio 30mg/30ml Concentrate for Solution for Infusion | 1’s,Concentrate for Solution for Infusion Vial, 1’s | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | F.HoffmannLaRocheLtd., |
| Qatar | (L01FY01) pertuzumab and trastuzumab | PHESGO Injection (1200mg+600mg) | 1s,Vial Vial, 1s | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.HoffmannLaRocheLtd. |
| Qatar | (L01FY01) pertuzumab and trastuzumab | PHESGO Injection (600mg+600mg) | 1s,Vial Vial, 1s | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.HoffmannLaRocheLtd. |
| Qatar | (L01XA03) oxaliplatin | ELOXATIN 100MG/20ML CONCENTRATE FOR SOLUTION FOR INFUSION SOLUTION | 20ml Bottle,concentrate for solution for infusion (intravenous use) Bottle, 20ml Bottle | Retail price without vat |
$0-0 |
$0-0 |
n/a | SanofiAventisFrance |
| Qatar | (L01XA03) oxaliplatin | ELOXATIN 200MG/40ML CONCENTRATE FOR SOLUTION FOR INFUSION SOLUTION | 40ml Bottle,concentrate for solution for infusion (intravenous use) Bottle, 40ml Bottle | Retail price without vat |
$0-0 |
$0-0 |
n/a | SanofiAventisFrance |
| Qatar | (L01XA03) oxaliplatin | ELOXATIN 50MG/10ML CONCENTRATE FOR SOLUTION FOR INFUSION SOLUTION | 10ml Bottle,concentrate for solution for infusion (intravenous use) Bottle, 10ml Bottle | Retail price without vat |
$0-0 |
$0-0 |
n/a | SanofiAventisFrance |
| Qatar | (L01XC02) rituximab | Mabthera Solution for subcutaneous injection | 1 Vial of 15 ml,Vial containing solution for subcutaneous injection 15 mL colorless USP/Ph. Eur., Type I glass vial, sealed with a butyl rubber stopper laminated with fluoro-resin film, and crimped with an aluminum overseal fitted with a plastic flip-off disk in a carton box with leaflet., 1 Vial of 15 ml | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationLimited |
| Qatar | (L01XC02) rituximab | Mabthera 100mg/10ml Vial | 2 x 10ml Vial,I.V Infusion Glass Vials, 2 x 10ml Vial | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | F.HoffmannLaRocheLtd. |
| Qatar | (L01XC02) rituximab | Rixathon 100mg Vial | 2s*10ml,Vial Vial, 2s*10ml | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell; Wegener Granulomatosis; Microscopic Polyangiitis; Pemphigus | SandozGmbH |
Pages
